PEOPLE - Biophan Technologies makes appointment:
This article was originally published in Clinica
Executive Summary
Biophan Technologies has appointed John Lanzafame as president of the company's nanolution division. Mr Lanzafame will oversee the Rochester, New York-based firm's development of advanced nanotechnology-based drug delivery devices and drug-elution technologies, patents and products. He has worked in the device industry for over 15 years, most recently for STS Biopolymers, a firm recently acquired by Angiotech.